Skip to main content
Equibles
SMTI logo

SMTI · Sanara MedTech Inc.

Track SMTI — free

Use SMTI with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$34.68 -0.12 (-0.34%)
Russell 2000 member Rebalance outlook locked
Market Cap
$320.39M
Shares
9.19M

SMTI metrics

71 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$34.80
Market cap
$320.39M

Price action

19 metrics
Price change (1W)
+0.3%
Price change (30D)
+2.3%
Price change (3M)
+63.6%
Price change (6M)
+66.9%
Price change (YTD)
+49.0%
Price change (1Y)
+3.4%
Trailing year
Price change (5Y)
+2.3%
52-week high
$35.75
52-week low
$16.34
Change from 52-week high
-2.7%
Change from 52-week low
+112.9%
Annualized volatility
60.6%
Beta
0.8
RSI (14D)
78.4
Price vs SMA 50
+18.6%
Price vs SMA 200
+51.1%
Avg volume (3M)
217,171
Relative volume
0.9
Average dollar volume
$6.98M

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
9.19M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
2.9×
reciprocal yield 34.3%
P / book
40.3
reciprocal yield 2.5%
FCF yield
1.4%
TTM · current market cap
Buyback yield
—
P / FCF
71.1
reciprocal yield 1.4%
P / operating cash flow
56.3
reciprocal yield 1.8%
Earnings yield
-10.0%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
3.3×
reciprocal yield 30.5%
EV / revenue historical average (5Y)
3.8×
reciprocal yield 26.0%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
146.0×
reciprocal yield 0.7%
EV / EBITDA historical average (5Y)
146.0×
reciprocal yield 0.7%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-05-12

Profitability

9 metrics
Gross margin
93.0%
Operating margin
7.7%
Trailing 12 months
Net margin
-29.2%
Gross profit (TTM)
$102.16M
Operating profit (TTM)
$8.42M
Net income (TTM)
−$32.01M
Trailing 12 months
Diluted EPS (TTM)
$-3.72
FCF margin
4.1%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-0.03

Growth

11 metrics
Revenue growth YoY
+9.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$109.81M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
-3.0%
Year over year · fewer shares
Revenue CAGR (3Y)
+31.0%
Revenue CAGR (5Y)
+45.9%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-403.0%
Return on assets
-46.3%
Debt / equity
—
Current ratio
2.6
EBITDA (TTM)
$11.76M
Free cash flow (TTM)
$4.50M
Quick ratio
2.3
Interest coverage
1.2
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$15.42M
Total assets
$69.15M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$5.69M
Capital expenditures (TTM)
$1.19M
R&D (TTM)
$4.98M
SG&A (TTM)
$84.44M
Stock compensation (TTM)
$4.94M
R&D / revenue
4.5%
Stock compensation / revenue
4.5%

Ownership (13F)

3 metrics
13F filers
75
13F filer change QoQ
+9
Institutional ownership
19.4%

Short interest

3 metrics
Short interest
2.3%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
51 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 714256 CUSIP 79957L100 13F (30d) 60 filings 60 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)